George Medicines, Azurity Ink U.S. Widaplik Deal
July 21, 2025
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK tablets in the US George Medicines, a late-stage biopharmaceutical company focused on addressing